Cannabis addiction: signs, effects and treatment

Yes, though it’s more complicated than that. Whether you call it cannabis, weed, or marijuana, it has a reputation as a soft drug. It’s not physically addictive like alcohol or opioids. But dependence doesn’t require a physical withdrawal crisis to be real.

According to the European Union Drugs Agency (EUDA) 2025 European Drug Report, around 1.5% of EU adults use cannabis daily or almost daily. That’s approximately 4.3 million people. They are the group most likely to experience problems associated with their use. Cannabis is now responsible for more than one third of all drug treatment admissions across Europe.

Cannabis use disorder is a recognised clinical condition. It’s listed in both the International Classification of Diseases (ICD-11) and the American Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Both are clinical descriptions of patterns of use that cause genuine difficulty in someone’s life.

Problems tend to emerge with regular, long-term use of high-potency products, especially when use started young. Occasional recreational use is usually relatively, though not always, safer. Preventing cannabis addiction means understanding where your use sits on that spectrum.

For most people, it builds slowly, so slowly that it’s easy to miss. You need more cannabis to get the same effect. You feel restless or irritable without it. You reach for it more automatically than you used to.

Long-term THC use changes the brain physically. Research shows it reduces the number of receptors THC binds to (the CB1 receptors), and the ones that remain respond less. The brain adapts to sustained exposure to a psychoactive substance.

Once tolerance develops, a previously enjoyable thing starts to feel like a necessary one. By that point, the brain has changed shape around the habit, and cutting back is harder than it would have been a year earlier.

Not all cannabis carries the same risk. According to the same EUDA report, the average THC content of cannabis resin in Europe is now 23%, almost double what it was in 2013. Herbal cannabis averages around 11% THC. Higher-potency products are likely to carry higher dependence risk than the cannabis of previous generations.

Am I actually dependent on cannabis, or am I just a regular user? There’s no clean line, but there are patterns that point to a problem.

Signs that cannabis use may have become a dependence include:

• Finding it difficult to cut down or stop, even when you’ve decided to try
• Using cannabis first thing in the morning, or at times when you previously wouldn’t have
• Feeling irritable or unable to sleep without it
• Continuing to use even though it’s affecting your mood, or causing problems in relationships or at work
• Spending a lot of the day either using cannabis or recovering from it
• Craving it strongly when you haven’t used recently

If two or three of these feel familiar, our admissions team is a good place to start.

If you’re concerned about someone’s cannabis use rather than your own, the signs can be harder to see. This is partly because cannabis is so socially normal that it’s easy to feel like you’re overreacting.

The clearest signs are heavier daily use, unpredictable mood, and pulling away from people who used to matter. Heavy daily use is different to recreational use. It usually means using cannabis first thing in the morning, at inappropriate times like at work or school, and never going a day without it.

People with anxiety or depression often use cannabis to manage their symptoms. But cannabis can also worsen the symptoms of anxiety and depression, and may contribute to them developing in the first place. These things can both be true at once, and it’s difficult to know which came first.

The evidence on the psychosis risk is clearer. A 2024 study from King’s College London found that frequent cannabis use raises the risk of psychosis on its own, separate from any genetic predisposition. In both samples studied, this risk was highest among daily users of high-potency cannabis, defined as 10% THC content or above.

The link was present even after researchers stripped out genetic risk for schizophrenia. Cannabis itself appears to raise psychosis risk, rather than simply exposing a predisposition someone was already born with.

If you use high-potency cannabis daily, the elevated psychosis risk applies to you. For occasional or lower-strength use, the data looks very different, but you may still be at risk.

Cannabis withdrawal can produce symptoms that look a lot like a mental health condition. A low mood that lifts after a few weeks is often withdrawal, not depression. However, you may be experiencing symptoms of both. A proper clinical assessment can tell the difference.

Stopping cannabis can be uncomfortable. It’s not dangerous in the way quitting alcohol can be, but the first week or two is hard. Cannabis withdrawal syndrome is now formally recognised in both the DSM-5 and ICD-11.

Symptoms typically include:

• Irritability or agitation
• Anxiety and restlessness
• Sleep difficulties, including problems falling asleep and vivid or disturbing dreams
• Decreased appetite
• Low mood
• Physical discomfort, including headaches and stomach pain

Symptoms usually begin within the first few days of stopping and tend to peak around days seven to ten, before gradually easing. The sleep disruption can sometimes linger longer than other symptoms.

If you’ve tried to stop and found it harder than you expected, withdrawal is the likely reason. For heavier or longer-standing use, a supervised cannabi detox makes the first week more manageable.

There’s no approved medication for cannabis addiction. The evidence supports talking therapies instead. CBT (Cognitive Behavioural Therapy) helps people change the thought patterns that keep their use going. Motivational interviewing works with people’s uncertainty so they can find their own reasons for recovery.

The EUDA confirms these are the most well-researched approaches for cannabis problems. They’re commonly offered across European treatment services and have the strongest evidence base.

At Castle Health, inpatient treatment provides a structured residential environment where you can step away from the contexts and routines that sustain daily use. Outpatient treatment allows people to continue working and living at home while accessing regular therapeutic support. Both are delivered across our network, including Castle Craig in Scotland, Smarmore Castle in Ireland, and Beroendekliniken in Sweden.

The period after primary treatment is when relapse risk is highest. Both include two years of structured aftercare.

If you’re unsure what kind of support fits your situation, our admissions team can help you work that out. You can also read more about our cannabis addiction treatment or browse our wider drug addiction treatment offering.

No. Dependence develops with sustained use over time. The strongest predictor is how often someone uses, with high-potency products and an early start age adding to the risk.

No. CBD and THC act differently in the brain. CBD has weak activity at the CB1 receptors involved in cannabis dependence, and isn’t intoxicating. Cannabis use disorder is associated specifically with THC.

Yes. Cannabis use disorder is listed in both the ICD-11 and DSM-5. In practical terms: a GP can diagnose it. Treatment services can address it under a clinical code. Insurers treat it as a medical condition.

Yes, for some people. Sleep disruption is a recognised symptom of cannabis withdrawal and can persist longer than other symptoms. If you’re still having sleep problems weeks or months after stopping, a GP or addiction specialist can help work out what’s driving it.

Broadly, the same psychological therapies and group work apply. The main difference is that no medication is currently approved for cannabis addiction, so the work is primarily therapeutic. If you’ve been in treatment for another substance before, cannabis addiction treatment will feel familiar.